CellTrypase
Cell dissociation in biopharmaceutical manufacturing
Commercial Launch (2025)Active
Key Facts
Indication
Cell dissociation in biopharmaceutical manufacturing
Phase
Commercial Launch (2025)
Status
Active
Company
About c-Lecta
c-LEcta is a German biotechnology company and a subsidiary of the Kerry Group, focused on providing enzyme-based solutions for industrial applications in pharma and food. It utilizes its proprietary ENESYZ technology platform for enzyme discovery and strain engineering, offering products like DENARASE for nucleic acid removal in biopharma and Acrylerase for food safety. With over 120 employees and a fully integrated R&D-to-production facility, the company serves as a key innovation and supply partner in regulated markets.
View full company profile